Literature DB >> 21913202

Eczema.

Andrew Sohn1, Amylynne Frankel, Rita V Patel, Gary Goldenberg.   

Abstract

Atopic dermatitis, commonly known as eczema, is a common chronic, relapsing skin disease characterized by pruritus, disrupted epidermal barrier function, and immunoglobulin E-mediated sensitization to food and environmental allergens. Atopic dermatitis is a complex disease that arises from interactions between genes and the environment. Loci on several chromosomes have been identified, including a family of epithelium-related genes called the epidermal differentiation complex on chromosome 1q21. Mutations in filaggrin, a key protein in epidermal differentiation, have also been identified in early-onset and severe atopic dermatitis. There are 3 classical stages of eczema: infantile, childhood, and adulthood. The spectrum of eczema presentation varies widely from a variant that only affect the hand to major forms where a patient presents with erythroderma. The acute and subacute lesions of atopic dermatitis are often characterized by intensely pruritic, erythematous papules and vesicles with excoriations and a serous exudate. Chronic atopic dermatitis is exemplified by lichenified plaques and papules with excoriations. Atopic dermatitis patients are also at higher risk for skin infections, including bacterial and viral superinfections. Conventional therapy includes avoidance of irritants and potential allergens, as well as continued hydration of the skin with thick emollients. Topical corticosteroids and topical immunomodulators are often used primarily. Other therapies including phototherapy, antimicrobials, antihistamines, and systemic immunosuppressives are also options in certain situations.
© 2011 Mount Sinai School of Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21913202     DOI: 10.1002/msj.20289

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  6 in total

1.  Breastfeeding duration modifies the effect of smoking during pregnancy on eczema from early childhood to adolescence.

Authors:  Nandini Mukherjee; Thomas R Sutter; Syed Hasan Arshad; John W Holloway; Hongmei Zhang; Wilfried Karmaus
Journal:  Clin Exp Allergy       Date:  2018-12       Impact factor: 5.018

2.  Acquisition, remission, and persistence of eczema, asthma, and rhinitis in children.

Authors:  H Zhang; A Kaushal; N Soto-Ramírez; A H Ziyab; S Ewart; J W Holloway; W Karmaus; H Arshad
Journal:  Clin Exp Allergy       Date:  2018-02-27       Impact factor: 5.018

3.  DNA methylation of the filaggrin gene adds to the risk of eczema associated with loss-of-function variants.

Authors:  A H Ziyab; W Karmaus; J W Holloway; H Zhang; S Ewart; S H Arshad
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-09-25       Impact factor: 6.166

4.  LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy.

Authors:  John A Zebala; Alan Mundell; Linda Messinger; Craig E Griffin; Aaron D Schuler; Stuart J Kahn
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

5.  A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis.

Authors:  Stefano Togni; Giada Maramaldi; Francesco Di Pierro; Massimo Biondi
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-11-11

6.  Interactive effect of STAT6 and IL13 gene polymorphisms on eczema status: results from a longitudinal and a cross-sectional study.

Authors:  Ali H Ziyab; Gwyneth A Davies; Susan Ewart; Julian M Hopkin; Eric M Schauberger; Marsha Wills-Karp; John W Holloway; Syed Hasan Arshad; Hongmei Zhang; Wilfried Karmaus
Journal:  BMC Med Genet       Date:  2013-07-02       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.